Upgrade to SI Premium - Free Trial

Form EFFECT Nasus Pharma Ltd

September 14, 2026 6:03 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 11, 2026 4:15 P.M.
Form: F-3
CIK: 0002029039
Company Name: Nasus Pharma Ltd
File Number: 333-298693

Categories

SEC Filings